US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Boundless Bio, Inc.

3.00

+0.10003.45%

Post-market: 2.94-0.0600-2.00%18:23 EDT

Volume:157.16K

Turnover:468.69K

Market Cap:68.24M

PE:-1.05

High:3.02

Open:2.91

Low:2.91

Close:2.90

52wk High:3.02

52wk Low:0.9612

Shares:22.75M

Float Shares:16.09M

Volume Ratio:1.11

T/O Rate:0.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8563

EPS(LYR):-2.6027

ROE:-67.86%

ROA:-32.77%

PB:1.03

PE(LYR):-1.15

Loading ...

Overview Company News Filings

Boundless Bio announces annual shareholder meeting via online webcast

BOLD NEW LOOK, A BRIGHTER NEW MOOD: MIRINDA® LAUNCHES A "SMILE PLEASE" PLATFORM GLOBALLY

Boundless Bio presents preclinical data for BBI-940 therapy at AACR

Boundless Bio starts Phase 1 KOMODO-1 trial of BBI-940 in breast cancer

Boundless Bio Terminates Major Long-Term San Diego Lease

NurExone Wins BOLD Healthcare Award and Hires IBN to Boost Investor Visibility

Boundless Bio to present oral kinesin degrader program at AACR Annual Meeting 2026

Boundless Bio Inc. publishes corporate presentation on ecDNA-directed cancer therapies and BBI-940 Phase 1 trial

Boundless Bio Q4 EPS $(0.58) Misses $(0.52) Estimate

Benzinga Earnings

Boundless Bio Q4 net loss narrows 22% to USD 12.89 million as R&D spending falls 26% to USD 9.82 million

Boundless Bio Inc - Expects Cash to Fund Operations Into the Second Half of 2028

THOMSON REUTERS

Boundless Bio Inc - Q4 EPS $-0.58

THOMSON REUTERS

Press Release: Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Boundless Bio CEO Zachary Hornby to Join Fireside Chat at Leerink Global Healthcare Conference

Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial

Press Release: Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BOLD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BOLD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOLD\",,,,,undefined,":{"symbol":"BOLD","market":"US","secType":"STK","nameCN":"Boundless Bio, Inc.","latestPrice":3,"timestamp":1787342400000,"preClose":2.9,"halted":0,"volume":157157,"hourTrading":{"tag":"盘后","latestPrice":2.94,"preClose":3,"latestTime":"18:23 EDT","volume":278,"amount":833.96,"timestamp":1787351025400,"change":-0.06,"changeRate":-0.02,"amplitude":0.04},"delay":0,"changeRate":0.03448275862068969,"floatShares":16085900,"shares":22747985,"eps":-2.856339,"marketStatus":"Market Closed","change":0.1,"latestTime":"08-21 16:00:00 EDT","open":2.91,"high":3.02,"low":2.91,"amount":468687.2309119,"amplitude":0.037931,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.856339,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1711598400000,"exchange":"NASDAQ","adjPreClose":2.9,"preHourTrading":{"tag":"盘前","latestPrice":2.99,"preClose":2.9,"latestTime":"08:39 EDT","volume":17,"amount":48.9700011,"timestamp":1787315990006,"change":0.09,"changeRate":0.031034,"amplitude":0.096552},"postHourTrading":{"tag":"盘后","latestPrice":2.94,"preClose":3,"latestTime":"18:23 EDT","volume":278,"amount":833.96,"timestamp":1787351025400,"change":-0.06,"changeRate":-0.02,"amplitude":0.04},"volumeRatio":1.110866069994049},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOLD\",,,,,undefined,":{"symbol":"BOLD","floatShares":16085900,"roa":"-32.77%","roe":"-67.86%","lyrEps":-2.602728,"volumeRatio":1.110866069994049,"shares":22747985,"dividePrice":0,"high":3.02,"amplitude":0.037931,"preClose":2.9,"low":2.91,"week52Low":0.9612,"pbRate":"1.03","week52High":3.02,"institutionHeld":0,"latestPrice":3,"eps":-2.856339,"divideRate":0,"volume":157157,"delay":0,"ttmEps":-2.856339,"open":2.91,"prevYearClose":1.2,"prevWeekClose":2.83,"prevMonthClose":2.5,"prevQuarterClose":2.5,"fiveDayClose":2.83,"twentyDayClose":2.57,"sixtyDayClose":1.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BOLD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"BOLD","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2026-05-08","symbol":"BOLD","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2026-03-09","symbol":"BOLD","fiscalQuarterEnding":"2025/12","expectedEps":-0.44,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2025-11-05","symbol":"BOLD","fiscalQuarterEnding":"2025/09","expectedEps":-0.53,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2025-08-05","symbol":"BOLD","fiscalQuarterEnding":"2025/06","expectedEps":-0.75,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BOLD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BOLD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1748923200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BOLD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BOLD","date":"2026-08-21","current":-1.050296,"percent":0.291667,"low":-7.197589,"twenty":-1.278189,"median":-0.591619,"eighty":-0.420427,"high":-0.344156,"avg":-1.105039,"sd":1.218078,"marketCap":65964861},"quantilePoints":[{"date":"2024-03-28","current":-7.197589,"twenty":-7.197589,"median":-7.197589,"eighty":-7.197589,"marketCap":355805632},{"date":"2024-04-05","current":-5.848041,"twenty":-6.410353,"median":-6.108954,"eighty":-6.050474,"marketCap":289092076},{"date":"2024-04-12","current":-5.231748,"twenty":-6.126948,"median":-5.947008,"eighty":-5.398192,"marketCap":258626218},{"date":"2024-04-19","current":-5.083297,"twenty":-6.09096,"median":-5.501658,"eighty":-5.078799,"marketCap":251287727},{"date":"2024-04-26","current":-5.429681,"twenty":-6.050474,"median":-5.339712,"eighty":-4.853874,"marketCap":268410873},{"date":"2024-05-03","current":-4.071136,"twenty":-5.947008,"median":-5.193511,"eighty":-4.750409,"marketCap":201252560},{"date":"2024-05-10","current":-4.093629,"twenty":-5.848041,"median":-5.078799,"eighty":-4.498493,"marketCap":202364453},{"date":"2024-05-17","current":-4.480499,"twenty":-5.605123,"median":-4.907856,"eighty":-4.413022,"marketCap":221489005},{"date":"2024-05-24","current":-4.735651,"twenty":-5.429681,"median":-4.853874,"eighty":-4.413022,"marketCap":234102149},{"date":"2024-05-31","current":-3.818758,"twenty":-5.40449,"median":-4.780666,"eighty":-4.267271,"marketCap":202947870},{"date":"2024-06-07","current":-4.028119,"twenty":-5.351408,"median":-4.637315,"eighty":-4.062533,"marketCap":214074398},{"date":"2024-06-14","current":-2.746826,"twenty":-5.256939,"median":-4.498493,"eighty":-3.894843,"marketCap":145980047},{"date":"2024-06-21","current":-1.997311,"twenty":-5.233547,"median":-4.480499,"eighty":-3.836344,"marketCap":106147077},{"date":"2024-06-28","current":-1.62046,"twenty":-5.185863,"median":-4.433265,"eighty":-3.622795,"marketCap":86119326},{"date":"2024-07-05","current":-1.737702,"twenty":-5.126483,"median":-4.318554,"eighty":-2.862394,"marketCap":92350182},{"date":"2024-07-12","current":-1.708392,"twenty":-5.081498,"median":-4.206091,"eighty":-2.280368,"marketCap":90792468},{"date":"2024-07-19","current":-1.490655,"twenty":-5.078799,"median":-4.082382,"eighty":-1.861645,"marketCap":79220879},{"date":"2024-07-26","current":-1.553464,"twenty":-5.032015,"median":-4.019745,"eighty":-1.783761,"marketCap":82558837},{"date":"2024-08-02","current":-1.33154,"twenty":-4.961394,"median":-3.883354,"eighty":-1.756126,"marketCap":70764718},{"date":"2024-08-09","current":-1.285481,"twenty":-4.955327,"median":-3.848068,"eighty":-1.688293,"marketCap":68316881},{"date":"2024-08-16","current":-1.276053,"twenty":-4.909884,"median":-3.776885,"eighty":-1.61376,"marketCap":73657615},{"date":"2024-08-23","current":-1.441824,"twenty":-4.830482,"median":-3.580085,"eighty":-1.533365,"marketCap":83226429},{"date":"2024-08-30","current":-1.395563,"twenty":-4.789503,"median":-2.891285,"eighty":-1.49233,"marketCap":80556062},{"date":"2024-09-06","current":-1.206661,"twenty":-4.774615,"median":-2.543744,"eighty":-1.430642,"marketCap":69652065},{"date":"2024-09-13","current":-1.383997,"twenty":-4.747457,"median":-2.265294,"eighty":-1.38631,"marketCap":79888471},{"date":"2024-09-20","current":-1.696264,"twenty":-4.696317,"median":-1.886349,"eighty":-1.383997,"marketCap":97913446},{"date":"2024-09-27","current":-1.306894,"twenty":-4.531782,"median":-1.821447,"eighty":-1.360095,"marketCap":75437859},{"date":"2024-10-04","current":-1.225936,"twenty":-4.502092,"median":-1.785855,"eighty":-1.334651,"marketCap":70764718},{"date":"2024-10-11","current":-1.164254,"twenty":-4.498493,"median":-1.762826,"eighty":-1.315376,"marketCap":67204229},{"date":"2024-10-18","current":-1.175819,"twenty":-4.494894,"median":-1.752358,"eighty":-1.306512,"marketCap":67871820},{"date":"2024-10-25","current":-1.125702,"twenty":-4.475101,"median":-1.708392,"eighty":-1.277939,"marketCap":64978923},{"date":"2024-11-01","current":-1.148833,"twenty":-4.453508,"median":-1.660521,"eighty":-1.239044,"marketCap":66314106},{"date":"2024-11-08","current":-1.278189,"twenty":-4.445411,"median":-1.62046,"eighty":-1.227478,"marketCap":78044967},{"date":"2024-11-15","current":-1.099243,"twenty":-4.400426,"median":-1.603711,"eighty":-1.225936,"marketCap":67118671},{"date":"2024-11-22","current":-0.858213,"twenty":-4.337447,"median":-1.553464,"eighty":-1.206661,"marketCap":52401620},{"date":"2024-11-29","current":-0.996988,"twenty":-4.287064,"median":-1.515072,"eighty":-1.18353,"marketCap":60875074},{"date":"2024-12-06","current":-1.033507,"twenty":-4.282566,"median":-1.492749,"eighty":-1.171964,"marketCap":63104930},{"date":"2024-12-13","current":-0.898385,"twenty":-4.206091,"median":-1.45339,"eighty":-1.168109,"marketCap":54854462},{"date":"2024-12-20","current":-0.94586,"twenty":-4.174602,"median":-1.427126,"eighty":-1.164254,"marketCap":57753275},{"date":"2024-12-27","current":-0.931252,"twenty":-4.109824,"median":-1.4052,"eighty":-1.151917,"marketCap":56861333},{"date":"2025-01-03","current":-0.978728,"twenty":-4.080133,"median":-1.38978,"eighty":-1.137518,"marketCap":59760146},{"date":"2025-01-10","current":-0.883777,"twenty":-4.053929,"median":-1.382892,"eighty":-1.125702,"marketCap":53962520},{"date":"2025-01-17","current":-0.923948,"twenty":-4.024769,"median":-1.357011,"eighty":-1.113366,"marketCap":56415361},{"date":"2025-01-24","current":-0.880125,"twenty":-4.002159,"median":-1.351229,"eighty":-1.080253,"marketCap":53739534},{"date":"2025-01-31","current":-0.836301,"twenty":-3.925951,"median":-1.335808,"eighty":-1.010135,"marketCap":51063706},{"date":"2025-02-07","current":-0.810737,"twenty":-3.894843,"median":-1.330025,"eighty":-0.986762,"marketCap":49502807},{"date":"2025-02-14","current":-0.818041,"twenty":-3.863491,"median":-1.312677,"eighty":-0.98238,"marketCap":49948778},{"date":"2025-02-21","current":-0.715786,"twenty":-3.86063,"median":-1.307149,"eighty":-0.967772,"marketCap":43705181},{"date":"2025-02-28","current":-0.70483,"twenty":-3.848068,"median":-1.306417,"eighty":-0.938556,"marketCap":43036224},{"date":"2025-03-07","current":-0.617183,"twenty":-3.818758,"median":-1.293401,"eighty":-0.934904,"marketCap":37684569},{"date":"2025-03-14","current":-0.613531,"twenty":-3.802009,"median":-1.278189,"eighty":-0.9276,"marketCap":37461584},{"date":"2025-03-21","current":-0.642747,"twenty":-3.751762,"median":-1.256474,"eighty":-0.920296,"marketCap":39245469},{"date":"2025-03-28","current":-0.511724,"twenty":-3.651268,"median":-1.237502,"eighty":-0.912992,"marketCap":33447843},{"date":"2025-04-04","current":-0.443494,"twenty":-3.580085,"median":-1.233647,"eighty":-0.891081,"marketCap":28988130},{"date":"2025-04-11","current":-0.416203,"twenty":-3.232545,"median":-1.225936,"eighty":-0.861865,"marketCap":27204245},{"date":"2025-04-17","current":-0.484432,"twenty":-3.075105,"median":-1.212454,"eighty":-0.839223,"marketCap":31663958},{"date":"2025-04-25","current":-0.50149,"twenty":-2.80461,"median":-1.206661,"eighty":-0.818041,"marketCap":32778886},{"date":"2025-05-02","current":-0.547545,"twenty":-2.616184,"median":-1.18353,"eighty":-0.802703,"marketCap":35789192},{"date":"2025-05-09","current":-0.490678,"twenty":-2.519877,"median":-1.175819,"eighty":-0.736237,"marketCap":32233147},{"date":"2025-05-16","current":-0.562236,"twenty":-2.343176,"median":-1.171964,"eighty":-0.7041,"marketCap":36933814},{"date":"2025-05-23","current":-0.531568,"twenty":-2.272831,"median":-1.168109,"eighty":-0.640556,"marketCap":34919242},{"date":"2025-05-30","current":-0.398676,"twenty":-2.104504,"median":-1.164254,"eighty":-0.625217,"marketCap":26189432},{"date":"2025-06-06","current":-0.398676,"twenty":-1.939527,"median":-1.156544,"eighty":-0.615722,"marketCap":26189432},{"date":"2025-06-13","current":-0.371416,"twenty":-1.883418,"median":-1.150761,"eighty":-0.59381,"marketCap":24398701},{"date":"2025-06-20","current":-0.354379,"twenty":-1.864994,"median":-1.144978,"eighty":-0.584315,"marketCap":23279495},{"date":"2025-06-27","current":-0.364601,"twenty":-1.841546,"median":-1.129558,"eighty":-0.573359,"marketCap":23951019},{"date":"2025-07-03","current":-0.364601,"twenty":-1.81726,"median":-1.125702,"eighty":-0.562917,"marketCap":23951019},{"date":"2025-07-11","current":-0.402084,"twenty":-1.799673,"median":-1.119919,"eighty":-0.547886,"marketCap":26413273},{"date":"2025-07-18","current":-0.402084,"twenty":-1.792136,"median":-1.099243,"eighty":-0.532375,"marketCap":26413273},{"date":"2025-07-25","current":-0.425936,"twenty":-1.772875,"median":-1.068201,"eighty":-0.524876,"marketCap":27980162},{"date":"2025-08-01","current":-0.403787,"twenty":-1.762826,"median":-1.033507,"eighty":-0.512406,"marketCap":26525194},{"date":"2025-08-08","current":-0.396302,"twenty":-1.761988,"median":-0.996988,"eighty":-0.507716,"marketCap":25517908},{"date":"2025-08-15","current":-0.406731,"twenty":-1.757801,"median":-0.986032,"eighty":-0.494667,"marketCap":26189432},{"date":"2025-08-22","current":-0.396302,"twenty":-1.753614,"median":-0.98238,"eighty":-0.472151,"marketCap":25517908},{"date":"2025-08-29","current":-0.396302,"twenty":-1.747752,"median":-0.978728,"eighty":-0.443077,"marketCap":25517908},{"date":"2025-09-05","current":-0.392826,"twenty":-1.737702,"median":-0.967772,"eighty":-0.423026,"marketCap":25294066},{"date":"2025-09-12","current":-0.403255,"twenty":-1.708392,"median":-0.944034,"eighty":-0.416203,"marketCap":25965590},{"date":"2025-09-19","current":-0.396302,"twenty":-1.696264,"median":-0.938556,"eighty":-0.40938,"marketCap":25517908},{"date":"2025-09-26","current":-0.392826,"twenty":-1.674894,"median":-0.934904,"eighty":-0.406731,"marketCap":25294066},{"date":"2025-10-03","current":-0.420637,"twenty":-1.646147,"median":-0.9276,"eighty":-0.406731,"marketCap":27084797},{"date":"2025-10-10","current":-0.444971,"twenty":-1.624647,"median":-0.925774,"eighty":-0.406731,"marketCap":28651686},{"date":"2025-10-17","current":-0.490163,"twenty":-1.62046,"median":-0.920296,"eighty":-0.408899,"marketCap":31561623},{"date":"2025-10-24","current":-0.490163,"twenty":-1.616272,"median":-0.914818,"eighty":-0.40938,"marketCap":31561623},{"date":"2025-10-31","current":-0.479734,"twenty":-1.612085,"median":-0.912992,"eighty":-0.40938,"marketCap":30890099},{"date":"2025-11-07","current":-0.456671,"twenty":-1.595336,"median":-0.898385,"eighty":-0.410208,"marketCap":28204003},{"date":"2025-11-14","current":-0.434925,"twenty":-1.566026,"median":-0.891081,"eighty":-0.410208,"marketCap":26860956},{"date":"2025-11-21","current":-0.402305,"twenty":-1.553464,"median":-0.870995,"eighty":-0.410208,"marketCap":24846384},{"date":"2025-11-28","current":-0.424052,"twenty":-1.526666,"median":-0.858213,"eighty":-0.409519,"marketCap":26189432},{"date":"2025-12-05","current":-0.398681,"twenty":-1.516051,"median":-0.836301,"eighty":-0.408465,"marketCap":24622543},{"date":"2025-12-12","current":-0.416803,"twenty":-1.508938,"median":-0.819867,"eighty":-0.409284,"marketCap":25741749},{"date":"2025-12-19","current":-0.460295,"twenty":-1.497355,"median":-0.814389,"eighty":-0.40938,"marketCap":28427845},{"date":"2025-12-26","current":-0.438549,"twenty":-1.49233,"median":-0.803433,"eighty":-0.409484,"marketCap":27084797},{"date":"2026-01-02","current":-0.434925,"twenty":-1.481917,"median":-0.796129,"eighty":-0.409816,"marketCap":26860956},{"date":"2026-01-09","current":-0.474793,"twenty":-1.462642,"median":-0.734046,"eighty":-0.410208,"marketCap":29323210},{"date":"2026-01-16","current":-0.453047,"twenty":-1.448764,"median":-0.70483,"eighty":-0.411047,"marketCap":27980162},{"date":"2026-01-23","current":-0.460295,"twenty":-1.439029,"median":-0.701178,"eighty":-0.412481,"marketCap":28427845},{"date":"2026-01-30","current":-0.427676,"twenty":-1.427558,"median":-0.657354,"eighty":-0.413179,"marketCap":26413273},{"date":"2026-02-06","current":-0.395057,"twenty":-1.422549,"median":-0.629965,"eighty":-0.410208,"marketCap":24398701},{"date":"2026-02-13","current":-0.409554,"twenty":-1.406357,"median":-0.620835,"eighty":-0.409554,"marketCap":25294066},{"date":"2026-02-20","current":-0.427676,"twenty":-1.403273,"median":-0.619009,"eighty":-0.409554,"marketCap":26413273},{"date":"2026-02-27","current":-0.420427,"twenty":-1.395563,"median":-0.613531,"eighty":-0.409554,"marketCap":25965590},{"date":"2026-03-06","current":-0.40593,"twenty":-1.383997,"median":-0.593445,"eighty":-0.409554,"marketCap":25070225},{"date":"2026-03-13","current":-0.431227,"twenty":-1.383997,"median":-0.584315,"eighty":-0.409554,"marketCap":25096121},{"date":"2026-03-20","current":-0.442778,"twenty":-1.381787,"median":-0.575865,"eighty":-0.409554,"marketCap":25768338},{"date":"2026-03-27","current":-0.427377,"twenty":-1.372432,"median":-0.573359,"eighty":-0.410208,"marketCap":24872048},{"date":"2026-04-02","current":-0.435077,"twenty":-1.360095,"median":-0.565643,"eighty":-0.410208,"marketCap":25320193},{"date":"2026-04-10","current":-0.438928,"twenty":-1.356733,"median":-0.552175,"eighty":-0.411886,"marketCap":25544266},{"date":"2026-04-17","current":-0.627589,"twenty":-1.352316,"median":-0.555099,"eighty":-0.413004,"marketCap":36523819},{"date":"2026-04-24","current":-0.585237,"twenty":-1.340434,"median":-0.565643,"eighty":-0.413179,"marketCap":34059021},{"date":"2026-05-01","current":-0.562135,"twenty":-1.337735,"median":-0.565643,"eighty":-0.413179,"marketCap":32714586},{"date":"2026-05-08","current":-0.58935,"twenty":-1.334651,"median":-0.569672,"eighty":-0.413179,"marketCap":34298423},{"date":"2026-05-15","current":-0.620544,"twenty":-1.332008,"median":-0.575865,"eighty":-0.413179,"marketCap":34746768},{"date":"2026-05-22","current":-0.580509,"twenty":-1.330328,"median":-0.574612,"eighty":-0.414629,"marketCap":32505041},{"date":"2026-05-29","current":-0.584513,"twenty":-1.323086,"median":-0.576186,"eighty":-0.415492,"marketCap":32729214},{"date":"2026-06-05","current":-0.588516,"twenty":-1.316147,"median":-0.576506,"eighty":-0.416052,"marketCap":32953386},{"date":"2026-06-12","current":-0.556488,"twenty":-1.312291,"median":-0.575865,"eighty":-0.416563,"marketCap":31160005},{"date":"2026-06-18","current":-0.561626,"twenty":-1.309411,"median":-0.573359,"eighty":-0.416803,"marketCap":31447682},{"date":"2026-06-26","current":-1.006915,"twenty":-1.307201,"median":-0.573661,"eighty":-0.416803,"marketCap":56381201},{"date":"2026-07-02","current":-0.99488,"twenty":-1.306894,"median":-0.575865,"eighty":-0.416803,"marketCap":55707322},{"date":"2026-07-10","current":-1.006915,"twenty":-1.306799,"median":-0.576506,"eighty":-0.416874,"marketCap":56381201},{"date":"2026-07-17","current":-0.998892,"twenty":-1.305884,"median":-0.577536,"eighty":-0.41716,"marketCap":55931948},{"date":"2026-07-24","current":-1.010927,"twenty":-1.302839,"median":-0.582412,"eighty":-0.417278,"marketCap":56605827},{"date":"2026-07-31","current":-1.002903,"twenty":-1.299184,"median":-0.584315,"eighty":-0.417751,"marketCap":56156575},{"date":"2026-08-07","current":-1.139298,"twenty":-1.287619,"median":-0.585237,"eighty":-0.420427,"marketCap":63793869},{"date":"2026-08-14","current":-0.986089,"twenty":-1.285481,"median":-0.588516,"eighty":-0.420427,"marketCap":63121548},{"date":"2026-08-21","current":-1.030508,"twenty":-1.278189,"median":-0.591619,"eighty":-0.420427,"marketCap":65964861}],"updateTime":1787501739437},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BOLD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631538718","title":"Boundless Bio announces annual shareholder meeting via online webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2631538718","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631538718?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:01","pubTimestamp":1777406489,"startTime":"0","endTime":"0","summary":"Boundless Bio scheduled 2026 annual stockholder meeting for June 15, 2026, to be held online.Ballot includes election of James Christensen and Jennifer Lew as Class II directors, with terms running to 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boundless Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3vqX3X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630902375","title":"BOLD NEW LOOK, A BRIGHTER NEW MOOD: MIRINDA® LAUNCHES A \"SMILE PLEASE\" PLATFORM GLOBALLY","url":"https://stock-news.laohu8.com/highlight/detail?id=2630902375","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630902375?lang=en_us&edition=fundamental","pubTime":"2026-04-28 16:00","pubTimestamp":1777363200,"startTime":"0","endTime":"0","summary":"#SmilePlease global platform and refreshed global visual identity encourages a positive outlook and spontaneous moments of happiness, reinforcing Mirinda's commitment to bold, flavorful fun. PURCHASE,N.Y., April 28, 2026 /PRNewswire/ -- Today, Mirinda has unveiled a powerful new global platform 'Smile Please' alongside a fresh brand visual identity. The fun and impactful movement is designed to brighten everyday life, spark joy and create smiles from the first glance.","market":"other","thumbnail":"https://mma.prnewswire.com/media/2965265/PepsiCo_Mirinda_1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2965265/PepsiCo_Mirinda_1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/bold-new-look-a-brighter-new-mood-mirinda-launches-a-smile-please-platform-globally-302753336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOOD","BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628782509","title":"Boundless Bio presents preclinical data for BBI-940 therapy at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2628782509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628782509?lang=en_us&edition=fundamental","pubTime":"2026-04-18 05:00","pubTimestamp":1776459647,"startTime":"0","endTime":"0","summary":"Boundless Bio (BOLD) presents preclinical data supporting its lead ecDNA-directed therapy, BBI-940, at the American Association for Cancer Research...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/boundless-bio-presents-preclinical-data-for-bbi-940-therapy-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/boundless-bio-presents-preclinical-data-for-bbi-940-therapy-at-aacr-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628016784","title":"Boundless Bio starts Phase 1 KOMODO-1 trial of BBI-940 in breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628016784","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628016784?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:50","pubTimestamp":1776459002,"startTime":"0","endTime":"0","summary":"Boundless Bio flagged new preclinical breast cancer data for lead ecDNA-directed therapy BBI-940, an oral kinesin degrader now in Phase 1 KOMODO-1 trial .Results will be presented April 21, 2026 at AACR Annual Meeting in a late-breaking poster session.Data show BBI-940 drove antitumor activity in validated breast cancer models, with strongest effects in tumors characterized by extrachromosomal DNA.Company positioned findings as support for ongoing first-in-human development in advanced or metastatic ER+/HER2- breast cancer, with additional evaluation in TNBC-LAR.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL9HKbgj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","LU0314104364.USD","SG9999014013.SGD","BK4139","BOLD","SG9999014021.USD","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627469656","title":"Boundless Bio Terminates Major Long-Term San Diego Lease","url":"https://stock-news.laohu8.com/highlight/detail?id=2627469656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627469656?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:55","pubTimestamp":1776117334,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Boundless Bio Inc. ( ($BOLD) ). On April 13, 2026, Boundless Bio, Inc. agreed to terminate its lease for approx...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boundless-bio-terminates-major-long-term-san-diego-lease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boundless-bio-terminates-major-long-term-san-diego-lease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624545786","title":"NurExone Wins BOLD Healthcare Award and Hires IBN to Boost Investor Visibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2624545786","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624545786?lang=en_us&edition=fundamental","pubTime":"2026-04-02 02:26","pubTimestamp":1775068013,"startTime":"0","endTime":"0","summary":"An update from NurExone Biologic ( ($TSE:NRX) ) is now available. NurExone Biologic, a developer of exosome-based therapies for central nervous sys...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nurexone-wins-bold-healthcare-award-and-hires-ibn-to-boost-investor-visibility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nurexone-wins-bold-healthcare-award-and-hires-ibn-to-boost-investor-visibility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4523","LU0823039010.USD","BK4548","LU0181495838.USD","LU1102505762.USD","LU1102505929.USD","LU0307460401.USD","LU0823038988.USD","LU1868838027.USD","LABU","XLV","BOLD","XBI","BK4535","LU0029874061.USD","LU1805238398.USD","LU1868837565.USD","LU0231203729.USD","LU1267930656.SGD","HCSG","SG9999004220.SGD","LU0048575426.USD","LU0248272758.USD","BK4207","LU0128526141.USD","LU0143863198.USD","LU1048588211.SGD","LU1048596156.SGD","BK4581","LU0072462343.USD","LU0066902890.USD","LU0828237940.HKD","LU0264410563.USD","IE00B0JY6M65.USD","LU0164881194.USD","LU0287143357.SGD","LU1481012133.USD","BK4585","BK4588","LU1868837722.USD","IE00BYTNYM70.SGD","LU0197229882.USD","LU0261950470.USD","BK4139","BK4137","IE00B7N09G41.SGD","LU0143863784.USD","LU0708995666.HKD","LU0821914370.USD","IBN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620403203","title":"Boundless Bio to present oral kinesin degrader program at AACR Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403203","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403203?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:52","pubTimestamp":1773780757,"startTime":"0","endTime":"0","summary":"Boundless Bio will present a poster at the American Association for Cancer Research  Annual Meeting 2026, held April 17-22, 2026 in San Diego, California. The poster session is scheduled for April 21, 2026, 2:00 PM-5:00 PM PT . The presentation will cover preclinical work on BBI-940, an oral kinesin degrader program, under abstract LB361.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL2rWVQc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","NDAQ","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4112","LU2095319765.USD","BK4139","SG9999014039.USD","SG9999014021.USD","BK4588","BOLD","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618258656","title":"Boundless Bio Inc. publishes corporate presentation on ecDNA-directed cancer therapies and BBI-940 Phase 1 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618258656","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618258656?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:59","pubTimestamp":1773057566,"startTime":"0","endTime":"0","summary":"Boundless Bio outlined its strategy to develop extrachromosomal DNA -directed therapies for oncogene-amplified cancers, describing ecDNA as a driver of amplification and treatment resistance. The company said about 25% of cancer patients have amplified oncogenes, and about 54% of high-copy number oncogene amplifications are detected on ecDNA. Boundless Bio highlighted BBI-940, an oral kinesin degrader, with the KOMODO-1 Phase 1 first-in-human trial underway in patients with ER+/HER2- breast cancer and TNBC-LAR. It also described its Spyglass discovery platform, which it said uses ecDNA biology to identify synthetic lethal targets, and referenced additional programs including BBI-355  and BBI-825 .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL9snmqg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618288906","title":"Boundless Bio Q4 EPS $(0.58) Misses $(0.52) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618288906","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618288906?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:13","pubTimestamp":1773054787,"startTime":"0","endTime":"0","summary":"Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 21.62 percent increase over losses of $(0.74) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51122807/boundless-bio-q4-eps-0-58-misses-0-52-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618640400","title":"Boundless Bio Q4 net loss narrows 22% to USD 12.89 million as R&D spending falls 26% to USD 9.82 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640400?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:03","pubTimestamp":1773054189,"startTime":"0","endTime":"0","summary":"Boundless Bio reported a Q4 net loss of USD 12.89 million, narrowing 22% from the prior-year quarter. R&D expenses fell 26% to USD 9.82 million in Q4, while G&A expenses declined 16% to USD 4.19 million. For FY 2025, net loss was USD 58.2 million, narrowing 11%, as R&D expenses decreased 19% to USD 44.85 million. Cash, cash equivalents and short-term investments totaled USD 107.58 million at year-end, and the company said this is expected to fund operations into the second half of 2028 through an anticipated initial clinical proof-of-concept readout from the KOMODO-1 trial of BBI-940.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDLb8BKSt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","NDAQ","BOLD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4585","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","BK4139","BK4588","SG9999014039.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618407196","title":"Boundless Bio Inc - Expects Cash to Fund Operations Into the Second Half of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2618407196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618407196?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:00","pubTimestamp":1773054004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUA7K1ZC6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618026640","title":"Boundless Bio Inc - Q4 EPS $-0.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2618026640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618026640?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:00","pubTimestamp":1773054004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUA7K1ZC6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618640473","title":"Press Release: Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640473","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640473?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:00","pubTimestamp":1773054000,"startTime":"0","endTime":"0","summary":"KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment. $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1. SAN DIEGO, March 09, 2026  -- Boundless Bio , a clinical-stage oncology company interrogating extrachromosomal DNA  biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced financial results and business highlights for the fiscal quarter and full year ended December 31, 2025.\"With the KOMODO-1 trial of BBI-940 actively enrolling, we are excited to evaluate this potentially first-in-class oral Kinesin degrader in patients with breast cancer who are seeking new treatment options. BBI-940 is designed to disrupt ecDNA segregation and inheritance, a differentiated mechanism for targeting chromosomally unstable cancers. The Boundless team is focused on clinical execution and reaching an initial proof-of-concept readout wit","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616532755","title":"Boundless Bio CEO Zachary Hornby to Join Fireside Chat at Leerink Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532755","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616532755?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:02","pubTimestamp":1772625779,"startTime":"0","endTime":"0","summary":"Boundless Bio CEO Zachary Hornby to Join Fireside Chat at Leerink Global Healthcare Conference               Boundless Bio (Nasdaq: BOLD) said its President and CEO Zachary Hornby will participate in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL2Vd4vc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014021.USD","SG9999014013.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4112","BOLD","LU2210150020.SGD","IE00BKPKM429.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014005.SGD","LU0314104364.USD","NDAQ","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611975346","title":"Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2611975346","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611975346?lang=en_us&edition=fundamental","pubTime":"2026-02-13 00:31","pubTimestamp":1770913912,"startTime":"0","endTime":"0","summary":"Boundless Bio Inc. ($BOLD) announced an update on their ongoing clinical study. Boundless Bio Inc. (BOLD) has launched a first-in-human Phase 1 tri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boundless-bio-advances-new-breast-cancer-drug-bbi-940-into-first-in-human-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boundless-bio-advances-new-breast-cancer-drug-bbi-940-into-first-in-human-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BOLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610137659","title":"Press Release: Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2610137659","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610137659?lang=en_us&edition=fundamental","pubTime":"2026-02-12 14:00","pubTimestamp":1770876000,"startTime":"0","endTime":"0","summary":"-- FY 2025 sales growth of 10.9% at CER1, or 8.1% as reported, driven by. growth of the three therapeutic areas of Oncology , Rare Disease.  and Neuroscience ; Somatuline sales growth of 4.3%1,with all other products, excluding Somatuline, achieving double-digit. -- FY 2025 core operating income of EUR1,294m, growing by 16.7% as reported,with a core operating margin of 35.2% of total sales, increasing by. -- 2025 continued pipeline expansion, driven by significant regulatory and. clinical milestones, integration of multiple preclinical assets with. global rights and innovative approaches, and a mid-stage candidate from. addition to the full data readout for IPN10200 in an aesthetics. PARIS, FRANCE, 12 February 2026 - Ipsen , a global specialty-care biopharmaceutical company, today presents its financial results for the full year  2025 and for the fourth quarter of 2025.\"In 2025, Ipsen delivered strong sales and profit growth,\" said David Loew, Chief Executive Officer, Ipsen. \"We contin","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4080","EMA","BK4232","BK4231","BOLD","BK4081","BK4139","R","ADC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":56,"code":"91000000","status":"200"}]}}